retatrutide triple agonist obesity trial ⭐️topline results from TRIUMPH-1, a Phase 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon hormone receptor agonist, in adults with or “overweight” Retatrutide Strengthens Position in Obesity

[DOI] [PMC free article] [PubMed] [Google Scholar] 37.Marso S.P., Bain S.C., Consoli A., Eliaschewitz F.G., Jdar E., Leiter L.A., Lingvay I., Rosenstock J., Seufert J., Warren M.L., et al

Lepore, J

It is to make smaller meals more complete, so each one still supports muscle, digestion, hydration, and nutrient status

The Plate Strategy That Actually Works I'm not going to hand you a list of forbidden foods

For context, authorised incretin-based injectable medicines such as semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) have defined refrigerated storage conditions set out in their respective UK SmPCs

All authors participated in interpretation of the data and critical review of the paper, had full access to the data, and had responsibility for the decision to submit for publication